The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: Efficacy and safety data

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 1, 2006, Pages 36-42

  Flidel Rimon, Orna ^a,c   Friedman, Smadar ^a,c   Leibovitz, Eugene ^b   Shinwell, Eric S ^a,c  

^a KAPLAN MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; GENTAMICIN; METICILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRAIN HEMORRHAGE; CANDIDA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ENDOCARDITIS; ERADICATION THERAPY; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DISEASE; KLEBSIELLA; MAJOR CLINICAL STUDY; MEDICAL RECORD; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN SEPSIS; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; URINARY TRACT INFECTION;

AMIKACIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT, NEWBORN; PENICILLANIC ACID; PIPERACILLIN; RETROSPECTIVE STUDIES; SEPSIS;

EID: 31144436840     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500372879     Document Type: Article

References (22)

1. Klein, JO.(2001) Bacterial sepsis and meningitis. In Infectious diseases of the foetus and newborn infant 5th edn. (pp. 493-8).Philadelphia (PA): WB Saunders Co.
2. Makhoul, IR and Sujov, P and Smolkin, T and Lusky, A and Reichman, B and in collaboration with the Israel Neonatal Network. (2002) Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: A national survey Pediatrics, 109, pp. 34-9.
3. Baltimore, RS. (2003) Neonatal sepsis; epidemiology and management Pediatr Drugs, 5, pp. 723-40.
4. Flidel-Rimon, O and Friedman Even-Tov, S and Gradstein, S and Bradstein, R and Shinwell, ES. (2003) Reduction in prevalence of multi-resistant Klebsiella spp. causing neonatal sepsis following a change in empirical antibiotic treatment Acta Paediatrica, 92, pp. 1205-7.
5. Flidel-Rimon, O and Leibovitz, E and Juster-Reicher, A and Amitay, M and Miskin, A and Barak, Y and Mogilner, B. (1996) An outbreak of antibiotic multiresistant Klebsiella at the Neonatal Intensive Care Unit, Kaplan Hospital, Rehovot, Israel, November l99l to April l992 Am J Perinatol, 13, pp. 99-102.
6. Pillay, T and Pillay, DG and Adhikari, M and Sturm, AW. (1998) Piperacillin/tazobactam in treatment of Klebsiella pneumoniae infection in neonate Am J Perinatol, 15, pp. 47-51.
7. Kuye, O and Teal, J and DeVries, VG and Morrow, CA and Tally, FP. (1993) Safety profile of piperacillin/tazobactam in phase I and II clinical studies J Antimicrob Chemother, 31(Suppl A), pp. 113-24.
8. Perry, CM and Markham, A. (1999) Piperacillin/tazobactam: An updated review of its use in the treatment of bacterial infections Drugs, 57, pp. 805-43.
9. Fass, RJ and Copelan, A and Brandt, JT and Moeschberger, ML and Ashton, JJ. (1987) Platelet-mediated bleeding caused by broad-spectrum penicillins J Infec Dis, 155, pp. 1242-8.
10. Burroughs, SF and Johnson, GJ. (1990) Beta-lactam antibiotic-induced platelet dysfunction: Evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin Blood, 75, pp. 1473-80.
11. National Committee for Clinical Laboratory Standards Document M100-SB 940 West Valley Road. Suite 1400. Wayne PennsylvaniaPA19087 USA, 1998.
12. Sorgel, F and Kinzig, M. (1993) The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam J Antimicrob Chemother, 31, pp. 39-60.
13. Rice, LB. (1999) Successful interventions for Gram-negative resistance to extended spectrum β-lactam antibiotics Pharmacotherapy, 19, pp. S120-8.
14. Toltzis, P and Dul, MJ and Hoyen, C and Salvator, A and Walsh, M and Zetts, L and Toltzis, H. (2001) Molecular epidemiology of antibiotic-resistant Gram-negative bacilli in a neonatal intensive care unit during a non-outbreak period Pediatrics, 108, pp. 1143-8.
15. Toltzis, P. (2003) Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit Minerva Pediatr, 55, pp. 385-93.
16. Cordero, L and Rau, R and Taylor, D and Ayers, LW. (2004) Enteric Gram-negative bacilli bloodstream infections:17 y experience in a neonatal intensive care unit Am J Infect Contr, 32, pp. 189-95.
17. Hughes, WT and Armstrong, D and Bodey, GP and Bow, EJ and Brown, AE and Calandra, T and (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis, 34, pp. 730-51.
18. Bohme, A and Shah, PM and Stille, W and Hoelzer, D. (1998) Piperacillin/ tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenia patients; a prospective randomized pilot study Eur J Med Res, 3, pp. 324-30.
19. Del Favero A, Menichetti F, Martino P, Bucaneve G, Micozzi A, Gentile G, et al., and the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Programme. A multicentre, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empirical therapy for febrile neutropenia. Clin Infect Dis 2001;33:1295-1301.
20. Matrai-Kovalskis, Y and Greenberg, D and Shinwell, ES and Fraser, D and Dagan, R. (1998) Positive blood cultures for coagulase-negative staphylococci in neonates: Does highly selective vancomycin usage affect outcome? Infection, 26, pp. 85-92.
21. Linder, N and Haskin, O and Levi, O and Klinger, G and Prince, T and Naor, N and (2003) l. Risk factors for intraventricular haemorrhage in very low birth weight premature infants: A retrospective case-control study Pediatrics, 111, pp. 590-5.
22. Egarter, C and Leitich, H and Karas, H and Wieser, F and Husslein, P and Kaider, A and Schemper, M. (1996) Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: A meta-analysis Am J Obstet Gynecol, 174, pp. 589-97.